Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

You're thinking of participating in a clinical trial – what now? Ask questions and weigh the risks before deciding if a clinical trial is right for you.

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

Insilico Medicine pulls back the curtain on developmental timelines, highlighting a ~13 month average timeline to reach developmental candidate (DC) nomination across 22 programs. Insilico’s QPCTL ...

Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

NGM120 and aldafermin exemplify NGM’s leadership in discovering and developing novel clinical candidates that target disease-modifying biology across a range of ... NGM Bio’s EMERALD Phase 2 clinical ...

With a strong cash position of A$159.26 million, the company is well-funded for future operations and clinical trials. Immutep received regulatory approval for its pivotal TACTI-004 Phase III ...